Company Search:
Advanced Search
Sponsored Links
Nuevolution AB (publ) Company Snapshot
Nuevolution AB (publ) operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nuevolution AB (publ) with three other pharmaceutical manufacturers in Europe: Byotrol PLC of the United Kingdom (2017 sales of £3.13 million [US$4.37 million] of which 38% was Professional), Bonesupport Holding AB (129.30 million Swedish Kronor [US$15.80 million] ), and Erytech Pharma SA which is based in France (3.36 million Euro [US$4.16 million] ).

Sales Analysis. Sales increased substantially in 2017: During the year ended June of 2017, sales at Nuevolution AB (publ) were SEK 120.32 million (US$14.70 million). This is an increase of 464.5% versus 2016, when the company's sales were SEK 21.31 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nuevolution AB (publ)
  Stock Performance Chart for Nuevolution AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 17.24
(Figures in Swedish Kronor)
1 Week -4.1%   13 Weeks 1.5%  
4 Weeks 2.6%   52 Weeks 0.2%  
Nuevolution AB (publ) Key Data:
  Ticker: NUE Country: Denmark
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 120,318,000
(Year Ending Jan 2018).
Employees: 47
  Currency: Swedish Kronor Market Cap: 738,875,989
  Fiscal Yr Ends: June Shares Outstanding: 42,858,236
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.